Search

Learn how a new technology could improve detection and treatment of certain aggressive lung and prostate cancers.

… Friday, February 6, 2026 A new technology developed at Memorial Sloan Kettering Cancer Center (MSK) shows promise for improving the detection and treatment of aggressive forms of  lung cancer  and  prostate cancer . The approach uses radioactive agents that bind to a molecule on cancer cells called DLL3

To mark National Cancer Prevention Month this February, MSK shared several tips to help reduce the risk of developing cancer.

… Tuesday, February 16, 2021 Summary Advice supports mission of National Cancer Prevention Month, as COVID-19 pandemic leads to an alarming drop in cancer screenings, diagnoses and treatment nationwide. To mark National Cancer Prevention Month this February, Memorial Sloan Kettering Cancer Center (MSK)

Treating pituitary tumors with combination immunotherapy may be an effective treatment strategy, especially for tumors that are resistant to temozolomide.

… Friday, February 8, 2019 Our results suggest that clinical sequencing of pituitary tumors that have relapsed after treatment with traditional chemotherapy can identify mutations that may respond to immunotherapy. Andrew Lin Associate Attending Neurologist The response of patients with pituitary tumors

… Tuesday, March 10, 2026 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Luis Díaz Jr. Received the 2026 Gustave Roussy Award Luis Díaz Jr. Luis Díaz Jr., MD,   Gastrointestinal Medical Oncologist, received the 2026 Gustave Roussy Prize , which honors

… Friday, December 8, 2017 Summary More than 20 MSK physicians and researchers presented work at an annual breast cancer conference in San Antonio. The San Antonio Breast Cancer Symposium (SABCS) is marking its 40th anniversary this week. The annual conference has grown from a small gathering and now brings

Luis Felipe Somarribas Patterson joined the Santosha Vardhana Lab as a postdoc in 2021. He investigates how metabolism influences different cell types, including immune cells, and conducts research into “exhausted T cells,” a state of T cell dysfunction that arises during chronic infections and cancer.

… Wednesday, October 5, 2022   Luis Felipe Somarribas Patterson  joined the  Santosha Vardhana Lab  in Memorial Sloan Kettering Cancer Center’s Human Oncology & Pathogenesis Program as a postdoc in 2021. He investigates how metabolism influences different cell types, including immune cells, and conducts

Six young scientists at Memorial Sloan Kettering Cancer Center, Rockefeller University, and Weill Cornell Medical College have been named the inaugural winners of a new prize established to recognize postdoctoral investigators in the life sciences. The Tri-Institutional Breakout Awards for Junior Investigators, which include a $25,000 prize for each recipient, were established by three Tri-Institutional winners of the 2013 Breakthrough Prize in Life Science — one from each of the three institutions — with additional financial support from the institutions themselves.

… Monday, June 15, 2015 Six young scientists at Memorial Sloan Kettering Cancer Center (MSK), Rockefeller University, and Weill Cornell Medical College have been named the inaugural winners of a new prize established to recognize postdoctoral investigators in the life sciences. The Tri-Institutional Breakout

The June 15 edition of “MSK Science Spotlight,” features Derek Tan, PhD discussing “A Drug Discovery Journey from Tuberculosis to Cancer.”

… Monday, June 15, 2020 The June 15 edition of “ MSK Science Spotlight , ” features Derek Tan , PhD discussing “A Drug Discovery Journey from Tuberculosis to Cancer.” Dr. Tan is Chair of Chemical Biology Program at the Sloan Kettering Institute and Director of Tri-Institutional PhD Program in Chemical

In a world where one in every two people will be diagnosed with cancer in their lifetime, the Publicis Foundation is launching the first cross-industry coalition to erase the stigma of cancer in the workplace, supported by leading cancer charities and organizations including Memorial Sloan Kettering Cancer Center (MSK), MacMillan Cancer Support and the Gustave Roussy Institute.

… Tuesday, January 17, 2023 In a world where one in every two people will be diagnosed with cancer in their lifetime  (1) , the Publicis Foundation is launching the first cross-industry coalition to erase the stigma of cancer in the workplace, supported by leading cancer charities and organizations including

MSK physician-scientists presented breakthrough advances in new treatment approaches for several cancer types at the 2024 ASCO Annual Meeting.

… Tuesday, June 4, 2024 Memorial Sloan Kettering Cancer Center (MSK) researchers presented breakthrough advances in new treatment approaches for several cancer types at the 2024 ASCO Annual Meeting held May 31 to June 4, 2023, in Chicago. Highlights of practice-changing study results in HPV-associated